Table 1.

Schedule of enrolment, interventions, and assessments.

Item	Study period
	Screening	Baseline	Treatment	Follow-up
Timepoint	-1 week	0	4-weeks	8-weeks	12-weeks
Enrolment
Eligibility screen	×
Signed informed consent	×
Randomization		×
Interventions
Intervention group		×	×
Control group		×	×
Assessments
Primary outcome
VD		×	×	×	×
HD		×	×	×	×
Secondary outcomes
MAS		×	×	×	×
VAS		×	×	×	×
FMA-UE		×	×	×	×
MBI		×	×	×	×
Adverse Events		×	×	×	×

×Represents data collection timepoint. VD, Vertical distance; HD, Horizontal distance; MAS, Modified Ashworth Scale; VAS, Visual Analog Scale; FMA-UE, Fugl-Meyer Assessment of Upper Extremity function; MBI, Modified Barthel Index.